News Digest / Ticker: DERM

Ticker: DERM

05:18pm, Tuesday, Aug 12, 2025

Journey Medical: Emrosi Launch Lifts Revenue, But Losses, High Debt and Going Concern Remain

Journey Medical Corporation (NASDAQ: DERM) - Snapshot from 10‑Q (period ended June 30, 2025) Quick take: Journey Medical's commercial-stage dermatology business shows revenue stability and an initial commercial ramp for newly approved Emrosi, but the company remains loss-making, carrying a sizabl...

07:04am, Thursday, May 15, 2025

Journey Medical Reports Mixed Q1 2025 Results Amid Revenue Growth and Rising Operational Costs